Powered By
| The Axert brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Axert was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute migraine headaches with or without aura in people 12 and older. Axert was also known by its drug name, almotriptan.
Axert was a triptan. Triptans are believed to work by constricting blood vessels and reducing inflammation.
How was it taken?
Axert was generally taken once or twice a day. Axert came in tablet form.
Side effects
The FDA-approved label for Axert listed common side effects including dizziness, drowsiness, dry mouth, “pins and needles” tingling sensation, nausea, and vomiting.
Rare but serious side effects listed for Axert included decreased blood pressure, stroke, cerebral hemorrhage (bleeding), serotonin syndrome, medication overuse headache, ischemia (insufficient blood supply) to the heart, spleen, or gastrointestinal system, and sensation of tightness, heaviness, or pressure in the chest, throat, jaw, neck, or other body parts.
For more details about this treatment, visit:
More resources from MyMigraineTeam that mention Axert
Become a member to get even more
Join
